Verve Therapeutics, Inc. (VERV) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$4.68

$0.08

(1.63%)

Day's range

$4.5

$4.71

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$19.00

305.98% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
11/06/2024	H.C. Wainwright	Mitchell Kapoor	$14.00	$6.32	121.69%
04/03/2024	BMO Capital	Kostas Biliouris	$30.00	$8.57	250.06%

Verve Therapeutics, Inc. Frequently Asked Questions

What analysts cover Verve Therapeutics, Inc.?

Verve Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, BMO Capital, Goldman Sachs in the past 90 days.

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.